MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q1 2021. The put-call ratio across all filers is 5.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $14,224,000 | +97.4% | 515,000 | +0.4% | 0.30% | +65.0% |
| Q3 2020 | $7,204,000 | -31.3% | 512,711 | +0.8% | 0.18% | -36.5% |
| Q2 2020 | $10,483,000 | +177.7% | 508,411 | +1.7% | 0.29% | +84.6% |
| Q1 2020 | $3,775,000 | -51.4% | 500,000 | 0.0% | 0.16% | -36.3% |
| Q4 2019 | $7,760,000 | +231.6% | 500,000 | +11.1% | 0.24% | +163.4% |
| Q3 2019 | $2,340,000 | -42.5% | 450,000 | 0.0% | 0.09% | -36.7% |
| Q2 2019 | $4,073,000 | -50.9% | 450,000 | +29.5% | 0.15% | -54.1% |
| Q1 2019 | $8,295,000 | +45.5% | 347,500 | 0.0% | 0.32% | +19.0% |
| Q4 2018 | $5,702,000 | -38.2% | 347,500 | 0.0% | 0.27% | -19.5% |
| Q3 2018 | $9,226,000 | +36.7% | 347,500 | +17.8% | 0.33% | +28.5% |
| Q2 2018 | $6,749,000 | +7.5% | 295,100 | 0.0% | 0.26% | -3.0% |
| Q1 2018 | $6,277,000 | +68.3% | 295,100 | 0.0% | 0.27% | +58.6% |
| Q4 2017 | $3,730,000 | -18.3% | 295,100 | 0.0% | 0.17% | -19.9% |
| Q3 2017 | $4,565,000 | +160.1% | 295,100 | +96.7% | 0.21% | +137.1% |
| Q2 2017 | $1,755,000 | -0.3% | 150,000 | 0.0% | 0.09% | -12.7% |
| Q1 2017 | $1,761,000 | +57.9% | 150,000 | +67.4% | 0.10% | +36.0% |
| Q4 2016 | $1,115,000 | – | 89,600 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |